Skip to content

Marc Le Borgne

  • Ph-D, PharmD
  • University Claude Bernard Lyon 1
  • 17h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 822CitationsNumber of citations received by Marc's publications. Updated daily.

Research interests

Medicinal Chemistry

Co-authors (240)

Publications (5)

  • Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles

    • Prandina A
    • Herfindal L
    • Radix S
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7

    • Nacereddine A, Bollacke A, Róka E, Marminon C, Bouaziz Z, Fenyvesi F, Bácskay IK, Jose J, Perret F L
    N/AReaders
    N/ACitations
    Get full text
  • Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7

    • Nacereddine A
    • Bollacke A
    • Róka E
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Comparison of the in-vitro aromatase inhibitory activity of 3-(azolylmethyl)-1H-indoles

    • Le Borgne M
    • Marchand P
    • Duflos M
    • et al.
    N/AReaders
    4Citations
    Get full text
  • Synthesis and in vitro evaluation of 3-(1-Azolylmethyl)-1H-indoles and 3-(1-azoly1-1-phenylmethyl)-1H-indoles as inhibitors of P450 arom

    • Le Borgne M
    • Marchand P
    • Duflos M
    • et al.
    N/AReaders
    51Citations
    Get full text

Professional experience

Universite Lyon 1